Long-term follow-up of testicular cancer patients shows no predisposition to osteoporosis

被引:0
作者
N. Murugaesu
T. Powles
J. Bestwick
R. T. D. Oliver
J. Shamash
机构
[1] St Bartholomew’s Hospital,Department of Medical Oncology
[2] Gloucester House,undefined
来源
Osteoporosis International | 2009年 / 20卷
关键词
Chemotherapy; Osteoporosis; Testicular cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1627 / 1630
页数:3
相关论文
共 22 条
[1]  
Barrett-Connor E(1995)The economic and human costs of osteoporotic fracture Am J Med 98 3S-8S
[2]  
Riggs BL(1992)The prevention and treatment of osteoporosis N Engl J Med 327 620-627
[3]  
Melton LJ(1984)Drugs five years later. Cisplatin Ann Intern Med 100 704-713
[4]  
Loehrer PJ(1983)Factors affecting the pulmonary toxicity of bleomycin Acta Radiol Oncol 22 417-421
[5]  
Einhorn LH(1994)Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage J Clin Oncol 12 1063-1073
[6]  
Parvinen LM(2001)Osteoporosis in men: a potential role for the sex hormone binding globulin Bone 29 90-95
[7]  
Kilkku P(2006)Increased late toxicity in 12–20 year survivors of germ cell tumors (GCT) J Clin Oncol (Meeting Abstracts) 24 4509-6486
[8]  
Makinen E(2006)Effect of chemotherapy on skeletal health in male survivors from testicular cancer and lymphoma Clin Cancer Res 12 6480-1593
[9]  
van Leeuwen FE(2000)Osteoporosis due to cancer treatment: pathogenesis and management J Clin Oncol 18 1570-undefined
[10]  
Chorus AM(undefined)undefined undefined undefined undefined-undefined